0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027
Published Date: November 2021
|
Report Code: QYRE-Auto-7T7637
Home | Market Reports | Health | Reproductive Health
Global and China Prophylactic HIV Drug Market Insights Forecast to 2027

Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

Code: QYRE-Auto-7T7637
Report
November 2021
139 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
HIV is one of the leading cause of death worldwide affecting millions of people. HIV has become the chief contributor to the global burden diseases.
Market Analysis and Insights: Global and China Prophylactic HIV Drug Market
This report focuses on global and China Prophylactic HIV Drug market.
In 2020, the global Prophylactic HIV Drug market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Prophylactic HIV Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Prophylactic HIV Drug Scope and Market Size
Prophylactic HIV Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic HIV Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Prophylactic HIV Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Integrase Inhibitor

Segment by Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Gilead Sciences
Merck
Mylan
Cipla
Bristol-Myers Squibb
Roche
1 Study Coverage
1.1 Prophylactic HIV Drug Product Introduction
1.2 Market by Type
1.2.1 Global Prophylactic HIV Drug Market Size Growth Rate by Type
1.2.2 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
1.2.3 Integrase Inhibitor
1.3 Market by Application
1.3.1 Global Prophylactic HIV Drug Market Size Growth Rate by Application
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prophylactic HIV Drug Market Size, Estimates and Forecasts
2.1.1 Global Prophylactic HIV Drug Revenue 2016-2027
2.1.2 Global Prophylactic HIV Drug Sales 2016-2027
2.2 Global Prophylactic HIV Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Prophylactic HIV Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Prophylactic HIV Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Prophylactic HIV Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Prophylactic HIV Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Prophylactic HIV Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Prophylactic HIV Drug Revenue Forecast by Region (2022-2027)
3 Global Prophylactic HIV Drug Competitor Landscape by Players
3.1 Global Top Prophylactic HIV Drug Manufacturers by Sales
3.1.1 Global Prophylactic HIV Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Prophylactic HIV Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Prophylactic HIV Drug Manufacturers by Revenue
3.2.1 Key Prophylactic HIV Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Prophylactic HIV Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Prophylactic HIV Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Prophylactic HIV Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Prophylactic HIV Drug Revenue in 2020
3.2.6 Global Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Prophylactic HIV Drug Price by Manufacturers
3.4 Global Prophylactic HIV Drug Manufacturing Base Distribution, Product Types
3.4.1 Prophylactic HIV Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prophylactic HIV Drug Product Type
3.4.3 Date of International Manufacturers Enter into Prophylactic HIV Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Prophylactic HIV Drug Market Size by Type (2016-2021)
4.1.1 Global Prophylactic HIV Drug Sales by Type (2016-2021)
4.1.2 Global Prophylactic HIV Drug Revenue by Type (2016-2021)
4.1.3 Prophylactic HIV Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Prophylactic HIV Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Prophylactic HIV Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Prophylactic HIV Drug Revenue Forecast by Type (2022-2027)
4.2.3 Prophylactic HIV Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Prophylactic HIV Drug Market Size by Application (2016-2021)
5.1.1 Global Prophylactic HIV Drug Sales by Application (2016-2021)
5.1.2 Global Prophylactic HIV Drug Revenue by Application (2016-2021)
5.1.3 Prophylactic HIV Drug Price by Application (2016-2021)
5.2 Prophylactic HIV Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Prophylactic HIV Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Prophylactic HIV Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Prophylactic HIV Drug Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Prophylactic HIV Drug Market Size YoY Growth 2016-2027
6.1.1 China Prophylactic HIV Drug Sales YoY Growth 2016-2027
6.1.2 China Prophylactic HIV Drug Revenue YoY Growth 2016-2027
6.1.3 China Prophylactic HIV Drug Market Share in Global Market 2016-2027
6.2 China Prophylactic HIV Drug Market Size by Players (International and Local Players)
6.2.1 China Top Prophylactic HIV Drug Players by Sales (2016-2021)
6.2.2 China Top Prophylactic HIV Drug Players by Revenue (2016-2021)
6.3 China Prophylactic HIV Drug Historic Market Review by Type (2016-2021)
6.3.1 China Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
6.3.2 China Prophylactic HIV Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Prophylactic HIV Drug Price by Type (2016-2021)
6.4 China Prophylactic HIV Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Prophylactic HIV Drug Sales Forecast by Type (2022-2027)
6.4.2 China Prophylactic HIV Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Prophylactic HIV Drug Price Forecast by Type (2022-2027)
6.5 China Prophylactic HIV Drug Historic Market Review by Application (2016-2021)
6.5.1 China Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
6.5.2 China Prophylactic HIV Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Prophylactic HIV Drug Price by Application (2016-2021)
6.6 China Prophylactic HIV Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Prophylactic HIV Drug Sales Forecast by Application (2022-2027)
6.6.2 China Prophylactic HIV Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Prophylactic HIV Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Prophylactic HIV Drug Market Size YoY Growth 2016-2027
7.2 North America Prophylactic HIV Drug Market Facts & Figures by Country
7.2.1 North America Prophylactic HIV Drug Sales by Country (2016-2021)
7.2.2 North America Prophylactic HIV Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Prophylactic HIV Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Prophylactic HIV Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Prophylactic HIV Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Prophylactic HIV Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Prophylactic HIV Drug Market Size YoY Growth 2016-2027
9.2 Europe Prophylactic HIV Drug Market Facts & Figures by Country
9.2.1 Europe Prophylactic HIV Drug Sales by Country (2016-2021)
9.2.2 Europe Prophylactic HIV Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Prophylactic HIV Drug Market Size YoY Growth 2016-2027
10.2 Latin America Prophylactic HIV Drug Market Facts & Figures by Country
10.2.1 Latin America Prophylactic HIV Drug Sales by Country (2016-2021)
10.2.2 Latin America Prophylactic HIV Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Prophylactic HIV Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Prophylactic HIV Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Prophylactic HIV Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Prophylactic HIV Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Description and Business Overview
12.1.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Prophylactic HIV Drug Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Prophylactic HIV Drug Products Offered
12.2.5 Merck Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Prophylactic HIV Drug Products Offered
12.3.5 Mylan Recent Development
12.4 Cipla
12.4.1 Cipla Corporation Information
12.4.2 Cipla Description and Business Overview
12.4.3 Cipla Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cipla Prophylactic HIV Drug Products Offered
12.4.5 Cipla Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Corporation Information
12.5.2 Bristol-Myers Squibb Description and Business Overview
12.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bristol-Myers Squibb Prophylactic HIV Drug Products Offered
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Description and Business Overview
12.6.3 Roche Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Prophylactic HIV Drug Products Offered
12.6.5 Roche Recent Development
12.11 Gilead Sciences
12.11.1 Gilead Sciences Corporation Information
12.11.2 Gilead Sciences Description and Business Overview
12.11.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Gilead Sciences Prophylactic HIV Drug Products Offered
12.11.5 Gilead Sciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Prophylactic HIV Drug Industry Trends
13.2 Prophylactic HIV Drug Market Drivers
13.3 Prophylactic HIV Drug Market Challenges
13.4 Prophylactic HIV Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prophylactic HIV Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Prophylactic HIV Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
    Table 3. Major Manufacturers of Integrase Inhibitor
    Table 4. Global Prophylactic HIV Drug Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Prophylactic HIV Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Prophylactic HIV Drug Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Prophylactic HIV Drug Sales Market Share by Regions (2016-2021)
    Table 8. Global Prophylactic HIV Drug Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Prophylactic HIV Drug Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Prophylactic HIV Drug Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Prophylactic HIV Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Prophylactic HIV Drug Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Prophylactic HIV Drug Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Prophylactic HIV Drug Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Prophylactic HIV Drug Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Prophylactic HIV Drug Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Prophylactic HIV Drug Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Prophylactic HIV Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Prophylactic HIV Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic HIV Drug as of 2020)
    Table 20. Key Manufacturers Prophylactic HIV Drug Price (2016-2021) (USD/Unit)
    Table 21. Prophylactic HIV Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Prophylactic HIV Drug Product Type
    Table 23. Date of International Manufacturers Enter into Prophylactic HIV Drug Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Prophylactic HIV Drug Sales by Type (2016-2021) (K Units)
    Table 26. Global Prophylactic HIV Drug Sales Share by Type (2016-2021)
    Table 27. Global Prophylactic HIV Drug Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Prophylactic HIV Drug Revenue Share by Type (2016-2021)
    Table 29. Prophylactic HIV Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Table 30. Global Prophylactic HIV Drug Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Prophylactic HIV Drug Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Prophylactic HIV Drug Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Prophylactic HIV Drug Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Prophylactic HIV Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
    Table 35. Global Prophylactic HIV Drug Sales by Application (2016-2021) (K Units)
    Table 36. Global Prophylactic HIV Drug Sales Share by Application (2016-2021)
    Table 37. Global Prophylactic HIV Drug Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Prophylactic HIV Drug Revenue Share by Application (2016-2021)
    Table 39. Prophylactic HIV Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Table 40. Global Prophylactic HIV Drug Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Prophylactic HIV Drug Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Prophylactic HIV Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Prophylactic HIV Drug Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Prophylactic HIV Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
    Table 45. China Prophylactic HIV Drug Sales (K Units) of Key Companies (2016-2021)
    Table 46. China Prophylactic HIV Drug Sales Share by Company (2016-2021)
    Table 47. China Prophylactic HIV Drug Revenue (US$ Million) by Company (2016-2021)
    Table 48. China Prophylactic HIV Drug Revenue Share by Company (2016-2021)
    Table 49. China Prophylactic HIV Drug Sales (K Units) by Type (2016-2021)
    Table 50. China Prophylactic HIV Drug Sales Share by Type (2016-2021)
    Table 51. China Prophylactic HIV Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. China Prophylactic HIV Drug Price (USD/Unit) by Type (2016-2021)
    Table 53. China Prophylactic HIV Drug Sales (K Units) by Type (2022-2027)
    Table 54. China Prophylactic HIV Drug Sales Share by Type (2022-2027)
    Table 55. China Prophylactic HIV Drug Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. China Prophylactic HIV Drug Revenue Share by Type (2022-2027)
    Table 57. China Prophylactic HIV Drug Price (USD/Unit) by Type (2022-2027)
    Table 58. China Prophylactic HIV Drug Sales (K Units) by Application (2016-2021)
    Table 59. China Prophylactic HIV Drug Sales Share by Application (2016-2021)
    Table 60. China Prophylactic HIV Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. China Prophylactic HIV Drug Price (USD/Unit) by Application (2016-2021)
    Table 62. China Prophylactic HIV Drug Sales (K Units) by Application (2022-2027)
    Table 63. China Prophylactic HIV Drug Sales Share by Application (2022-2027)
    Table 64. China Prophylactic HIV Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. China Prophylactic HIV Drug Revenue Share by Application (2022-2027)
    Table 66. China Prophylactic HIV Drug Price (USD/Unit) by Application (2022-2027)
    Table 67. North America Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
    Table 68. North America Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
    Table 69. North America Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Prophylactic HIV Drug Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Prophylactic HIV Drug Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Prophylactic HIV Drug Revenue Market Share by Region (2016-2021)
    Table 75. Europe Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
    Table 77. Europe Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
    Table 87. Gilead Sciences Corporation Information
    Table 88. Gilead Sciences Description and Business Overview
    Table 89. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 90. Gilead Sciences Prophylactic HIV Drug Product
    Table 91. Gilead Sciences Recent Development
    Table 92. Merck Corporation Information
    Table 93. Merck Description and Business Overview
    Table 94. Merck Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 95. Merck Product
    Table 96. Merck Recent Development
    Table 97. Mylan Corporation Information
    Table 98. Mylan Description and Business Overview
    Table 99. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 100. Mylan Product
    Table 101. Mylan Recent Development
    Table 102. Cipla Corporation Information
    Table 103. Cipla Description and Business Overview
    Table 104. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 105. Cipla Product
    Table 106. Cipla Recent Development
    Table 107. Bristol-Myers Squibb Corporation Information
    Table 108. Bristol-Myers Squibb Description and Business Overview
    Table 109. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 110. Bristol-Myers Squibb Product
    Table 111. Bristol-Myers Squibb Recent Development
    Table 112. Roche Corporation Information
    Table 113. Roche Description and Business Overview
    Table 114. Roche Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 115. Roche Product
    Table 116. Roche Recent Development
    Table 117. Prophylactic HIV Drug Market Trends
    Table 118. Prophylactic HIV Drug Market Drivers
    Table 119. Prophylactic HIV Drug Market Challenges
    Table 120. Prophylactic HIV Drug Market Restraints
    Table 121. Prophylactic HIV Drug Customers List
    Table 122. Prophylactic HIV Drug Distributors List
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prophylactic HIV Drug Product Picture
    Figure 2. Global Prophylactic HIV Drug Sales Market Share by Type in 2020 & 2027
    Figure 3. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) Product Picture
    Figure 4. Integrase Inhibitor Product Picture
    Figure 5. Global Prophylactic HIV Drug Sales Market Share by Application in 2020 & 2027
    Figure 6. Hospital Pharmacy
    Figure 7. Retail Pharmacy
    Figure 8. Online Pharmacy
    Figure 9. Prophylactic HIV Drug Report Years Considered
    Figure 10. Global Prophylactic HIV Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Prophylactic HIV Drug Market Size 2016-2027 (US$ Million)
    Figure 12. Global Prophylactic HIV Drug Sales 2016-2027 (K Units)
    Figure 13. Global Prophylactic HIV Drug Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
    Figure 15. Global Prophylactic HIV Drug Sales Market Share by Region in 2020
    Figure 16. Global Prophylactic HIV Drug Revenue Market Share by Region (2016-2021)
    Figure 17. Global Prophylactic HIV Drug Revenue Market Share by Region in 2020
    Figure 18. Global Prophylactic HIV Drug Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Prophylactic HIV Drug Revenue in 2020
    Figure 20. Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
    Figure 22. Global Prophylactic HIV Drug Sales Market Share by Type in 2020
    Figure 23. Global Prophylactic HIV Drug Revenue Market Share by Type (2016-2021)
    Figure 24. Global Prophylactic HIV Drug Revenue Market Share by Type in 2020
    Figure 25. Global Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
    Figure 26. Global Prophylactic HIV Drug Sales Market Share by Application in 2020
    Figure 27. Global Prophylactic HIV Drug Revenue Market Share by Application (2016-2021)
    Figure 28. Global Prophylactic HIV Drug Revenue Market Share by Application in 2020
    Figure 29. China Prophylactic HIV Drug Sales Growth Rate 2016-2027 (K Units)
    Figure 30. China Prophylactic HIV Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. China Prophylactic HIV Drug Market Share in Global Market 2016-2027
    Figure 32. China 5 and 10 Largest Prophylactic HIV Drug Players Market Share by Revenue in Prophylactic HIV Drug in 2020
    Figure 33. China Prophylactic HIV Drug Revenue Share by Type (2016-2021)
    Figure 34. China Prophylactic HIV Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. China Prophylactic HIV Drug Revenue Share by Application (2016-2021)
    Figure 36. China Prophylactic HIV Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Prophylactic HIV Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 38. North America Prophylactic HIV Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Prophylactic HIV Drug Sales Market Share by Country in 2020
    Figure 40. North America Prophylactic HIV Drug Revenue Market Share by Country in 2020
    Figure 41. U.S. Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 42. U.S. Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 44. Canada Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Prophylactic HIV Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 46. Europe Prophylactic HIV Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Prophylactic HIV Drug Sales Market Share by Country in 2020
    Figure 48. Europe Prophylactic HIV Drug Revenue Market Share by Country in 2020
    Figure 49. Germany Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 50. Germany Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 52. France Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 54. U.K. Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 56. Italy Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Russia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Prophylactic HIV Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 60. Asia Pacific Prophylactic HIV Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Prophylactic HIV Drug Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Prophylactic HIV Drug Revenue Market Share by Region in 2020
    Figure 63. China Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 64. China Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 66. Japan Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 68. South Korea Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 70. India Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 72. Australia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Taiwan Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 74. Taiwan Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 76. Indonesia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Thailand Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Malaysia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Philippines Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 82. Philippines Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Vietnam Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 84. Vietnam Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Latin America Prophylactic HIV Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 86. Latin America Prophylactic HIV Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 87. Latin America Prophylactic HIV Drug Sales Market Share by Country in 2020
    Figure 88. Latin America Prophylactic HIV Drug Revenue Market Share by Country in 2020
    Figure 89. Mexico Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Mexico Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Brazil Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 92. Brazil Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Argentina Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 94. Argentina Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Middle East and Africa Prophylactic HIV Drug Sales Growth Rate 2016-2021 (K Units)
    Figure 96. Middle East and Africa Prophylactic HIV Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 97. Middle East and Africa Prophylactic HIV Drug Sales Market Share by Country in 2020
    Figure 98. Middle East and Africa Prophylactic HIV Drug Revenue Market Share by Country in 2020
    Figure 99. Turkey Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 100. Turkey Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Saudi Arabia Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 102. Saudi Arabia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. U.A.E Prophylactic HIV Drug Sales Growth Rate (2016-2021) (K Units)
    Figure 104. U.A.E Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. Prophylactic HIV Drug Value Chain
    Figure 106. Channels of Distribution
    Figure 107. Distributors Profiles
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Video Colposcope Market Insights and Forecast to 2028
Global Video Colposcope Market Insights and Forecast to 2028

Colposcopy is a medical diagnostic procedure to examine an illuminated magnified view of the cervix and the tissues of the vagina and vulva.Market Analysis and Insights Global Video Colposcope MarketDue to the COVID19 pandemic the global Video Colposcope market size is estimated to be worth US 164 million in 2022 and is forecast to a readjusted size of US 222.2 million by 2028 with a CAGR of 5.2 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-29B9117
Mon Jan 10 00:00:00 UTC 2022

Add to Cart

Global Hotpot Enhancer Market Insights and Forecast to 2028
Global Hotpot Enhancer Market Insights and Forecast to 2028

It can be added in the hotpot base in use or may be added separately.Market Analysis and Insights Global Hotpot Enhancer MarketDue to the COVID19 pandemic the global Hotpot Enhancer market size is estimated to be worth US 16 million in 2022 and is forecast to a readjusted size of US 17 million by 2028 with a CAGR of 1.1 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-0B889
Mon Jan 10 00:00:00 UTC 2022

Add to Cart

Global Endometrial Biopsy Catheter Market Insights and Forecast to 2028
Global Endometrial Biopsy Catheter Market Insights and Forecast to 2028

Market Analysis and Insights Global Endometrial Biopsy Catheter MarketDue to the COVID19 pandemic the global Endometrial Biopsy Catheter market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-4C9454
Mon Jan 10 00:00:00 UTC 2022

Add to Cart

Global Fertility and Pregnancy Rapid Test Kits Market Insights and Forecast to 2028
Global Fertility and Pregnancy Rapid Test Kits Market Insights and Forecast to 2028

While Pharmacies Drugstores segment is altered to an CAGR throughout this forecast period.Global Fertility and Pregnancy Rapid Test Kits Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-32T9154
Mon Jan 10 00:00:00 UTC 2022

Add to Cart